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1. Introduction
  Polycystic ovary syndrome (PCOS) is a common endocrine 
disturbance disease leading to the reproductive dysfunction 
in females. The main manifestations are anovulia or oligo-
ovulation, hyperandrogenism, hyperinsulinemia, fat and so 
on. The incidence rate of female in child-bearing period is 
5%-10%[1,2]. The pathogenesis of PCOS is not very clear, and 
because of its strong familial aggregation, many researchers 
believe that its incidence is related to the hereditary factors 
and may be the results of the interaction of gene and 
environment factor. The recent studies[3] show that chronic 
subclinical inflammation is closely related to the incidence 
of PCOS. IL-1, as an important cell inflammatory factor, 
plays an important role in cell growth, cell differentiation 
and immune response, and the levels of IL-1毬 and IL-1Ra 
in blood serum of PCOS patients increase significantly[4]. In 
order to explore the relationship between IL-1毬, IL-1Ra 
and PCOS incidence, this work detected the levels of IL-1
毬 and IL-1Ra in blood serum of PCOS patients and the 
gene polymorphism, and made the contrastive analysis with 
the healthy control group, aiming at providing new clues for 
genetic studies of PCOS.  
Objective: To explore the relationship between IL-1毬, IL-1Ra gene polymorphism and the 
occurrence of polycystic ovary syndrome (PCOS) infertility. Methods: A total of 59 PCOS infertility 
cases visiting the reproductive center of our hospital from Mar. 2010 to Mar. 2012 and 56 healthy 
women were selected. ELISA method was used for the detection of IL-1毬, IL-1Ra levels, and the 
levels of serum supersensitivity C reaction protein (US-CRP), insulin (FINS), follicule-stimulating 
hormone (FSH) and fasting blood-glucose (FBG) were detected. PCR analysis technology was 
adopted to detect the gene polymorphism of the 511 site of IL-1毬 and the second introne of IL-
1Ra. Results: The levels of IL-1毬, IL-1Ra, US-CRP, FINS and FBG in blood serum of patients 
in PCOS group were significantly higher than those in control group (P<0.05 or P<0.01). The level 
of FSH in PCOS group was significantly lower than that in control group (P<0.05). The genotypic 
frequency of T/T, the 511 site of IL-1毬 in PCOS group was 42.37%, significantly higher than 
12.50% in control group (P<0.01). The frequency of T allele was also significantly higher than that 
in control group (P<0.01). The genotypic frequency of 栺/桋, the second introne of IL-1Ra in PCOS 
group was 20.34%, signiciantly higher than 3.57% in control group (P<0.05). The frequency of 桋 
allele in PCOS group was significantly higher than that in control group (P<0.05). Conclusions: 
T allele of the 511 site of IL-1毬 gene and 桋 allele of the second introne of IL-1Ra gene might 
be the genetic basis of the rising of IL-1毬, IL-1Ra and US-CRP levels in blood serum of PCOS 
patients, and are associated with the infertility occurrence of PCOS patients.
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2.  Material and methods
2.1. General information
  Fifty-nine PCOS infertility patients with age (29.75
暲3.62) years old, vsiting reproductive center of our 
hospital from Mar. 2010 to Mar. 2012, were selected. The 
inclusion criteria took the diagnostic standard which 
was established by European Human Reproduction and 
Embryology Association and American Reproductive 
Medical Association in May, 2003 as the reference[5]. That 
was: 1) oligo-ovulation or anovulia; 2) having the clinical or 
biochemistry manifestation of hyperandrogenism; 3) ovarian 
polycystic changes (any one ovary existed twelve or more 
than twelve follicles with diameter 2-9 mm, or the ovarian 
volume increased more than 10 mL). The patients should 
meet two of the three items and patients with other diseases 
(congenital adrenal hyperplasia, androgen secretory tumor, 
Cushing’s symptom complex) must be excluded. Another 
fifty-six cases of healthy women who received treatment 
because of their husband with azoospermatism in the same 
period were selected as the control group. Their ages were 
(29.83暲3.91) years old; the menstrual cycle was normal; the 
basal body temperature was biphasic; serum hormone level 
and ultrasonic inspection were normal; bilateral tubal was 
patent. Other endocrine diseases should be excluded for all 
subjects investigated. They had no the history of hormone 
drugs application within three months, and had no diseases 
of heart, liver, kidney and others. All of the subjects signed 
the informed consent. 
2.2. Methods
2.2.1. Laboratory parameter detection 
  Five mL venous blood was drawn in the condition of 
limosis from all subjects investigated in the 3-5 d of the 
menstrual cycle (when dominant follicle were not found on 
PCOS amenorrhea patients in B-ultrasound examination), 
and the following laboratory parameters were detected. 
1) IL-1毬 and IL-1Ra levels were detected using ELISA 
method (ELISA kit, made by American Biosource Company); 
2) supersensitivity C reaction protein (US-CRP) level was 
detected using latex-enhanced immunoturbidimetry 
(AU5400 automatic biochemical analyzer, Japanese Olympus 
Company); 3) insulin (FINS) and follicule-stimulating 
hormone (FSH) levels were detected using enzyme 
amplification chemoluminescence method; 4) fasting blood-
glucose (FBG) level was detected using glucose oxidase 
method.
2.2.2. DNA extraction
  Two mL peripheral venous blood was drawn in the 
condition of limosis from all subjects investigated, and 
0.2% EDTA-Na2 was used for anticoagulation. The modified 
salting-out method[6] was used for DNA extraction (Genomic 
DNA fast extraction kit, Beijing SBS Genetech Co., Ltd.), and 
the DNA was kept under 70 曟 for test.
2.2.3. Detection of IL-1毬 511 site gene polymorphism
  The  pr imer  was  des igned and synthes ized by 
Invitrogen Company. The upstream primer was 5’-
TGGCATTGATCTGGTTCATC-3’ and the downstream 
primer was 5’- GTTTAGGAATC- TTCCCACTT -3’. PCR 
reaction system: 2 毺L DNA sample, 2.5 毺L 10暳PCR buffer 
solution, 0.5 毺L dNTP, 0.5 毺L Taq DNA polymerase, 
0.5 毺L upstream primer and 0.5 毺L downstream primer, 
sterile deionized water supplemented to 25 毺L, blending. 
PCR cyclic conditions: pre-denaturation at 95 曟 for 5 min; 
denaturation at 94 曟 for 40 s, annealing at 51曟 for 40 s, 
elongation at 72 曟 for 30 s, and 33 cycles in total; elongation 
at 72 曟 for 5 min. After 2% agarose gel electrophoresis, the 
allele type of IL-1毬 511 site was obtained according to the 
electrophoresis results. Gene counting method was used for 
calculating gene frequency. 
2.2.4. Gene polymorphism detection of the second Introne of 
IL-1Ra
  The  pr imer  was  des igned and synthes ized by 
Invitrogen Company. The upstream primer was 5’-
CTCAGCAACACACCTAT-3’ and the downstream primer was 
5’- TCCTGGTCTGCAGGT- AA-3’. PCR reaction system: 25 毺L
of the total volume, 2 毺L DNA sample, 2.5 毺L 10暳PCR 
buffer solution, 0.5 毺L dNTP, 0.5 毺L Taq DNA polymerase, 
0.5 毺L upstream primer and 0.5 毺L downstream primer. 
PCR cyclic conditions: pre-denaturation at 94 曟 for 5 min; 
denaturation at 95 曟 for 30 s, annealing at 55 曟 for 30 s, 
elongation at 72 曟 for 30 s, and 30 cycles in total; elongation 
at 72 曟 for 5 min. After 2% agarose gel electrophoresis, the 
allele type of the second introne of IL-1Ra was obtained 
according to the electrophoresis results. Gene counting 
method was used for calculating gene frequency. 
2.3. Statistical analysis
  SPSS15.0 software was used for statistical treatment and 
allele frequency and genotype distribution in each group 
were calculated. The goodness-of-fit 氈
2 was used for 
inspecting if the genotype distribution frequency was accord 
with Hardy-Weinberg balance. Analysis of variance, t test 
or 氈
2 test was used for the comparison of clinical and 
laboratory parameters between different genotypes. P<0.05 
indicated that there were statistical significance.
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3. Results
3.1. Comparison of IL-1毬, IL-1Ra, US-CRP, FINS, FSH 
and FBG levels between two groups
  The levels of IL-1毬, IL-1Ra, US-CRP, FINS and FBG in 
PCOS group were significantly higher than those in control 
group (P<0.05 or P<0.01); FSH level in PCOS group was 
significantly lower than that in control group (P<0.05) (Table 
1).
3.2. Results of IL-1毬 and IL-1Ra genotype detection in 
PCOS group
  There were three kinds of genes in 511 site of IL-1毬: TT 
type (only appearing one strap, 304 bp), CT type (appearing 
three straps, 304 bp, 190 bp and 114 bp) and CC type 
(appearing two straps, 190 bp and 114 bp) (Figure 1). The 
gene polymorphism of IL-1Ra was expressed as existing 86 
bp variable number of tandem repeat (VNTR) in the second 
introne and four kinds of allelic products, 410, 595, 240 and 
325 bp, which were corresponding to four alleles of IL-1Ra, 
IL-1Ra *1 (栺), IL-1Ra *5 (桋), IL-1Ra *2 (栻) and IL-1Ra *4 
(桇) (Figure 2).
Table 1 
Comparison of each indicator of patient serology in two groups.
Items PCOS group 
(n=59)
Control group 
(n=56)
t value P value
IL-1毬 (ng/L) 138.76暲35.35 107.23暲41.89 4.37 <0.01
IL-1Ra (ng/L) 273.73暲89.45 219.90暲85.51 3.29 <0.01
US-CRP (mg/L)    1.58暲0.63    1.07暲0.49 4.83 <0.01
FINS (mU/L)  18.65暲9.32  14.51暲8.99 2.42 <0.05
FSH (IU/L)    6.29暲1.27    6.85暲1.61 2.08 <0.05
FBG (mmol/L)    5.26暲0.61    4.85暲0.77 3.17 <0.01
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Figure 1. Gene polymorphism electrophoretogram at 511 site of IL-1
毬.
Note: M indicated DNA marker; 1-3 indicated the three genotypes at 
511 site of IL-1毬, CT type, CC type and TT type.
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Figure 2.  Gene polymorphism electrophoretogram of IL-1Ra.
Note: M indicted DNA marker; 1-4 indicated the four genotypes at the 
second introne of IL-1Ra, 栻/栻 type, 栺/栺 type, 栺/桋 type and 栺/桇 
type.
3.3. Comparison of genotypes and allele frequency 
distribution at 511 site of IL-1毬 between the two groups 
  The genotype frequency of T/T at 511 site of IL-1毬 in 
PCOS group was 42.37%, significantly higher than that 
12.50% in control group (氈
2=12.78, P<0.01). There existed C 
and T, the two kinds of allele at the 511 site of IL-1毬, and T 
allele frequency in PCOS group was significantly higher than 
that in control group (氈
2=9.19, P<0.01) (Table 2).
Table 2
Comparison of genotypes and allele frequency distribution at 511 site 
of IL-1毬 between the two groups [Type (%)].
Groups n Genotype frequency Allele frequency
C/C C/T T/T C T
Con t ro l 
group
56 18(32.14) 31(55.36) 7(12.50) 67(59.82) 45(40.18)
P C O S 
group
59 13(22.03) 21(35.59) 25(42.37) 47(39.83) 71(60.17)
Total 115 31(26.96) 52(45.22) 32(27.83) 114(49.57) 116(50.43)
3.4. Comparison of genotypes and allele frequency 
distribution at the second introne of IL-1Ra between two 
groups
  The genotype frequency of T/V at the second introne of IL-
1Ra in PCOS group was 20.34%, significantly higher than 
that 3.57% in control group (氈
2=9.32, P<0.05). There existed 
栺, 栻, 桇 and 桋 alleles of IL-1Ra, and 桋 allele frequency 
in PCOS group was significantly higher than that in control 
group (氈
2=9.99 , P<0.05) (Table 3).
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Table 3 
Comparison of genotypes and allele frequency distribution at the 
second introne of IL-1Ra between the two groups [Type (%)].
Groups n Genotype frequency Allele frequency
栺/栺 栺/桇 栺/桋 栻/栻 栺 栻 桇 桋
C o n t r o l 
group
56 52
(92.86)
1
(1.79)
2
(3.57)
1
(1.79)
107
(95.54)
2
(1.79)
1
(0.89)
2
(1.79)
P C O S 
group
59 47
(79.66)
0
(0.00)
12
(20.34)
0
(0.00)
106
(90.18)
0
(0.00)
0
(0.00)
12
(9.82)
Total 115 99
(86.09)
1
(0.87)
14
(12.17)
1
(0.87)
213
(92.61)
2
(0.87)
1
(0.43)
14
(6.09)
4. Discussion
  PCOS is a kind of female endocrine and metabolic disorder 
disease and the main manifestations are oligomenorrhea 
or even amenorrhea, anovulia, hyperandrogenism, 
hyperinsulinemia, and easily leading to type栻diabetes, 
fat and other metabolic diseases. In this work, the levels 
of FINS and FBG in PCOS group were significantly higher 
than those in control group (P<0.05 or P<0.01). CRP is an 
important inflammatory mediator and regulated by blood 
serum TNF-栻, IL-1 and other factors. It participates in 
various inflammatory reactions and is a sensitive indicator 
of subclinical system infection[7]. In this work, the level of 
US-CRP in PCOS patient blood serum increased (P<0.01).  
  Recently, the studies on the related genes of PCOS 
inheritance are focused on the related genes of sex hormone 
regulation, steroid hormone biosynthesis, cardiovascular 
risk and insulin sensitivity[8,9]. The latest studies discover 
that chronic subclinical inflammation is closely related to 
PCOS[10], especially for IL-1 family, the important markers 
of inflammatory reaction, which not only play the role of 
regulation and induction in the process of cell growth, 
differentiation and immune response, but also influence 
the process of ovulation and pregnancy[11]. IL-1 in ovary 
comes from ovarian granular cells and macrophages, and 
can promote the proliferation of granular cells and inhibit 
the generation effect of FSH on trophic hormone in granular 
cells. Before ovulation, IL-1 which is secreted in follicle can 
regulate granular cells to synthesize prostaglandin, activator 
of plasminogen and mucoprotein, and regulate the activation 
of collagenase, which plays an important role in ovulation. 
After ovulation, IL-1 can enhance the luteal function of 
granular cell through paracrine manner, which can make the 
dissolved activities of protein and collagenous fibre in ovary 
stop in time after ovulation[12-14].            
  The domestic and foreign scholars have made numerous 
studies on the relationship between PCOS and IL-1 gene, 
and they have discovered that the increase of IL-1毬, IL-
1Ra and US-CRP levels in patient blood serum may be 
related to the occurrence of PCOS[15,16]. Through the studies 
of PCOS patients in Caucasus area, some scholars have found 
that the gene polymorphism at C-889T site of IL-1毬 gene 
is related to the occurrence of PCOS, while the fifth exon 
of IL-1毬 gene and the gene polymorphism of IL-1Ra are 
unrelated to PCOS occurrence and its clinical features[17,18]. 
Another study has shown that IL-1毬 gene and IL-6 gene-
597 polymorphism are related to PCOS occurrence[19]. The 
results of this work showed that the levels of IL-1毬, IL-
1Ra, US-CRP, FINS and FBG in PCOS patient blood serum 
were significantly higher than those in control group (P<0.05 
or P<0.01); FSH level was lower than that in control group 
(P<0.05). The results were the same with part of Poldan 
research results and the reasons might me closely related 
to metabolic syndrome of PCOS patients, with most PCOS 
patients getting adiposity. It has been recognized that 
lipocyte is a kind of endocrine cell[21,22] and can secrete a 
large number of inflammatory factors.
  This work also discovered that T/T genotype frequency and 
T allele frequency at 511 site of IL-1毬 were higher than 
those in control group (P<0.01); 栺/桋 genotype frequency 
and 桋 allele frequency were higher than those in control 
group (P<0.05). It could be concluded that the 511 site of 
IL-1毬 and the genotype frequency of IL-1Ra might be 
the genetic bases for the increase of IL-1毬 and IL-1Ra 
levels in PCOS patient blood serum, and were related to the 
occurrence of PCOS sterility. Namely, females with T allele 
at the 511 site of IL-1毬 and 桋 allele carried by IL-1Ra had 
more tendency of PCOS sterility.
  In sum, this work explored the relationship between 
inflammatory cytokines and PCOS sterility, and the results 
showed that T allele at the 511 site of IL-1毬 gene and 桋 
allele in the second introne of IL-1Ra gene might be the 
genetic bases for the increase of IL-1毬, IL-1Ra and US-
CRP levels in PCOS patient blood serum, and were related 
to the occurrence of PCOS sterility. Meanwhile, females with 
the previous two alleles had more tendency of PCOS sterility. 
The patients with these high-risk genes should make 
early prevention and avoid the occurrence of metabolic 
disturbance and other long-term complications. 
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